Lesinurad Lesinurad (RDEA594) is a selective inhibitor of URAT1 in the proximal tubules of the kidney (Shahid and Singh, 2015)
Propensity score matching (PSM) was employed to create two cohorts: A GLP-1 agonists group and a control group without GLP-1 agonists usage
Margonis, G
Campolo J, Bernardi S, Cozzi L, Rocchiccioli S, Dellanoce C, Cecchettini A, Tonini A, Parolini M, Chiara BD, Micheloni G, Pelosi G, Passino C, Giannattasio C, Parodi O
Abnormal TGF-beta-1 signaling degrades the extracellular matrix and stimulates nerve growth factor, potentially increasing pain
Instead of saying "I feel sick some days," you can say "My symptoms correlate precisely with predicted concentration peaks, suggesting a lower peak via dose splitting might resolve them while maintaining therapeutic trough levels." That is the kind of data-driven conversation that leads to better outcomes